quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:20:22·9h
SECFiling
Edwards Lifesciences Corporation logo

Edwards Lifesciences Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

EW· Edwards Lifesciences Corporation
Health Care
Original source

Companies

  • EW
    Edwards Lifesciences Corporation
    Health Care

Recent analyst ratings

  • Apr 1UpdateWolfe Research$92.00
  • Jan 9UpdateTD Cowen$97.00
  • Dec 18UpdateAnalyst$100.00
  • Nov 3UpdateRaymond James$96.00
  • Oct 29UpdateWolfe Research-
  • Oct 29UpdateJefferies$98.00

Related

  • PR9h
    Edwards Lifesciences Reports First Quarter Results
  • PR7d
    Edwards Lifesciences to Host Earnings Conference Call on April 23, 2026
  • INSIDER14d
    SEC Form 4 filed by Ullem Scott B.
  • INSIDER17d
    SEC Form 4 filed by Lippis Daniel J.
  • INSIDER21d
    SEC Form 4 filed by Bobo Donald E Jr
  • ANALYST22d
    Edwards Lifesciences upgraded by Wolfe Research with a new price target
  • PR24d
    Two Year Data on Edwards Lifesciences' EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits
  • SEC28d
    Amendment: SEC Form SCHEDULE 13G/A filed by Edwards Lifesciences Corporation
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022